Clinical Trial Update: Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating toripalimab in combination with radiotherapy for nodal-positive, hormone receptor-positive breast cancer is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Breast Adenocarcinoma | Phase 2 | Status: RECRUITING